Live Breaking News & Updates on Department Of Biotherapy

Stay updated with breaking news from Department of biotherapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ASCO 2024: Camrelizumab plus Apatinib for Previously Treated Advanced Adrenocortical Carcinoma: A Single-Arm, Open-Label, Phase 2 Trial.

Advanced adrenocortical carcinoma, camrelizumab, Apatinib, Camrelizumab plus Apatinib. ....

United States , Zhigong Wei , Society Of Urologic Oncology , American Society Of Clinical Oncology , University Of Toronto , Sichuan University , Department Of Biotherapy , Cancer Center , Clinical Oncology , Annual Meeting , West China Hospital , Rashid Sayyid , Urologic Oncology , Clinical Fellow , Advanced Adrenocortical ,

Nanoparticle-Based Drug Delivery System for Inflammation

Dr Yu Zheng, together with her graduate student Qin Qin (from the Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University), developed and wrote the review. ....

Lyu Zheng , Megan Craig , Sichuan International Medical Exchange Promotion Association , Key Laboratory Of Biotherapy , Cancer Center , Department Of Biotherapy , Sichuan University , State Key Laboratory , West China Hospital , Based Drug Delivery System , Inflammation Treatment , Sichuan International Medical Exchange , Materials Industry Focus ,